Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis
Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis
Background: recent observational studies examining the association between Helicobacter pylori infection and the risk of metabolic dysfunction-associated steatotic liver disease (MASLD) have reported conflicting results. We performed a meta-analysis to quantify the magnitude of the association between H. pylori infection and the risk of MASLD.
Methods: we systematically searched three large electronic databases to identify eligible observational studies (published up to 30 November 2023) in which liver biopsy, imaging methods or blood-based biomarkers/scores were used for diagnosing MASLD. Data from selected studies were extracted, and meta-analysis was performed using common and random-effects modelling. Statistical heterogeneity among published studies, subgroup analyses, meta-regression analyses and publication bias were assessed.
Results: a total of 28 observational studies (24 cross-sectional and 4 longitudinal studies) were identified, including 231 291 middle-aged individuals of predominantly Asian ethnicity (~95%). Meta-analysis of cross-sectional studies showed that H. pylori infection was significantly associated with a small increase in the risk of prevalent MASLD (n = 24 studies; random-effects odds ratio 1.11, 95% CI 1.05–1.18; I2 = 63%). Meta-analysis of data from longitudinal studies showed that H. pylori infection was significantly associated with an increased risk of developing incident MASLD over a mean 5-year follow-up (n = 4 studies; random-effects odds ratio 1.20, 95%CI 1.08–1.33; I2 = 44%). Sensitivity analyses did not modify these results. The funnel plot did not reveal any significant publication bias.
Conclusions: H. pylori infection is associated with a mildly increased risk of prevalent and incident MASLD. Further well-designed prospective and mechanistic studies are required to better decipher the complex link between H. pylori infection and the risk of MASLD.
Helicobacter pylori, MASLD, NAFLD, metabolic dysfunction-associated steatotic liver disease, non-alcoholic fatty liver disease
1513-1525
Mantovani, Alessandro
37012dc6-b09a-452f-b37f-1872e12f0169
Lando, Maria Giovanna
7ec4bd13-f2e3-4d11-9138-e09186f3629a
Borella, Nicolò
6a703683-8bca-4751-8265-486d91615a8e
Scoccia, Enrico
e9341fc4-e7d4-4b33-9d45-122ab613346d
Pecoraro, Barbara
600d4e17-b18a-4d86-9822-91e9d810568a
Gobbi, Federico
7482b01a-5c72-4642-ae5a-21254eefa88a
Bisoffi, Zeno
3a464ef4-3130-4896-8765-398a8034731b
Valenti, Luca
d98d1029-65f6-40ba-9179-e5627de0080b
Tilg, Herbert
2a1f1540-0e25-48b6-872f-8033a76566fa
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Targher, Giovanni
6b6485f5-88e8-40d5-90cd-862ec6c1964f
July 2024
Mantovani, Alessandro
37012dc6-b09a-452f-b37f-1872e12f0169
Lando, Maria Giovanna
7ec4bd13-f2e3-4d11-9138-e09186f3629a
Borella, Nicolò
6a703683-8bca-4751-8265-486d91615a8e
Scoccia, Enrico
e9341fc4-e7d4-4b33-9d45-122ab613346d
Pecoraro, Barbara
600d4e17-b18a-4d86-9822-91e9d810568a
Gobbi, Federico
7482b01a-5c72-4642-ae5a-21254eefa88a
Bisoffi, Zeno
3a464ef4-3130-4896-8765-398a8034731b
Valenti, Luca
d98d1029-65f6-40ba-9179-e5627de0080b
Tilg, Herbert
2a1f1540-0e25-48b6-872f-8033a76566fa
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Targher, Giovanni
6b6485f5-88e8-40d5-90cd-862ec6c1964f
Mantovani, Alessandro, Lando, Maria Giovanna, Borella, Nicolò, Scoccia, Enrico, Pecoraro, Barbara, Gobbi, Federico, Bisoffi, Zeno, Valenti, Luca, Tilg, Herbert, Byrne, Christopher D. and Targher, Giovanni
(2024)
Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: an updated meta-analysis.
Liver International, 44 (7), .
(doi:10.1111/liv.15925).
Abstract
Background: recent observational studies examining the association between Helicobacter pylori infection and the risk of metabolic dysfunction-associated steatotic liver disease (MASLD) have reported conflicting results. We performed a meta-analysis to quantify the magnitude of the association between H. pylori infection and the risk of MASLD.
Methods: we systematically searched three large electronic databases to identify eligible observational studies (published up to 30 November 2023) in which liver biopsy, imaging methods or blood-based biomarkers/scores were used for diagnosing MASLD. Data from selected studies were extracted, and meta-analysis was performed using common and random-effects modelling. Statistical heterogeneity among published studies, subgroup analyses, meta-regression analyses and publication bias were assessed.
Results: a total of 28 observational studies (24 cross-sectional and 4 longitudinal studies) were identified, including 231 291 middle-aged individuals of predominantly Asian ethnicity (~95%). Meta-analysis of cross-sectional studies showed that H. pylori infection was significantly associated with a small increase in the risk of prevalent MASLD (n = 24 studies; random-effects odds ratio 1.11, 95% CI 1.05–1.18; I2 = 63%). Meta-analysis of data from longitudinal studies showed that H. pylori infection was significantly associated with an increased risk of developing incident MASLD over a mean 5-year follow-up (n = 4 studies; random-effects odds ratio 1.20, 95%CI 1.08–1.33; I2 = 44%). Sensitivity analyses did not modify these results. The funnel plot did not reveal any significant publication bias.
Conclusions: H. pylori infection is associated with a mildly increased risk of prevalent and incident MASLD. Further well-designed prospective and mechanistic studies are required to better decipher the complex link between H. pylori infection and the risk of MASLD.
Text
Helicobacter pylori and MASLD risk_R1_clean copy
- Accepted Manuscript
Text
Online-only Supplementary Material_R1
- Accepted Manuscript
Text
Figure 1
- Accepted Manuscript
Text
Figure 2
- Accepted Manuscript
Restricted to Repository staff only until 3 April 2025.
Request a copy
Text
Liver International - 2024 - Mantovani - Relationship between Helicobacter pylori infection and risk of metabolic
- Version of Record
Show all 5 downloads.
More information
Accepted/In Press date: 22 March 2024
e-pub ahead of print date: 3 April 2024
Published date: July 2024
Additional Information:
Publisher Copyright:
© 2024 The Authors. Liver International published by John Wiley & Sons Ltd.
Keywords:
Helicobacter pylori, MASLD, NAFLD, metabolic dysfunction-associated steatotic liver disease, non-alcoholic fatty liver disease
Identifiers
Local EPrints ID: 488719
URI: http://eprints.soton.ac.uk/id/eprint/488719
ISSN: 1478-3223
PURE UUID: 659cfea7-7cac-41e9-92ab-a4ee882979ef
Catalogue record
Date deposited: 04 Apr 2024 16:56
Last modified: 10 Aug 2024 01:36
Export record
Altmetrics
Contributors
Author:
Alessandro Mantovani
Author:
Maria Giovanna Lando
Author:
Nicolò Borella
Author:
Enrico Scoccia
Author:
Barbara Pecoraro
Author:
Federico Gobbi
Author:
Zeno Bisoffi
Author:
Luca Valenti
Author:
Herbert Tilg
Author:
Giovanni Targher
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics